Pre-exposure prophylaxis (PrEP) has the potential to become a powerful biomedical approach to HIV prevention; however, its success depends on behavioral and social factors that may determine its appropriate use. This article is designed to facilitate interdisciplinary empirical analogies relevant to PrEP implementation, reviewing behavioral and social science findings that may provide lessons critical to the success of PrEP as a biomedical–behavioral prevention strategy. As we prepare for the dissemination of new biomedical approaches to HIV prevention, integrating the state of the science across disciplines may result in innovative strategies for implementation that can enhance their success.
CDC: HIV/AIDS Surveillance Report, 2004. Atlanta: US Department of Health and Human Services; 2005.
UNAIDS &AIDS Vaccine Advocacy Coalition. Good participatory practice: Guidelines for biomedical HIV prevention trials. Geneva, Switzerland: 2007.
• Hirsch-Moverman Y, Daftary A, Franks J, Colson PW: Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008, 12:1235–1254. This review syntehsizes information from over 70 studies regarding predictors of LTBI adherence and intervention efficacy. LTBI provides a useful model for understanding determinants of PrEP as a long-term, daily prophylactic treatment. PubMed
Garcia-Lerma JG, Paxton L, Kilmarx PH, Heneine W: Oral pre-exposure prophylaxis for HIV prevention. Trends Pharmacol Sci 2009, In press.
•• Visschers VH, Meertens RM, Passchier WW, de Vries NN: Probability information in risk communication: a review of the research literature. Risk Anal 2009, 29:267–287. This article provides an excellent meta-analysis as well as detailed, specific recommendations for communication about probability and risk to patients. CrossRefPubMed
Kahneman D, Tversky A: Prospect theory: An analysis of decisions under risk. Econometrica 1979, 47:263–291. CrossRef
• Mahajan AP, Sayles JN, Patel VA, et al.: Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS 2008, 22(Suppl 2):S67–S79. This article presents an important review of the scientific literature on HIV/AIDS stigma and explores critical challenges to future research, but also provides recommendations for the next steps in responding to stigma in the context of the HIV/AIDS epidemic. CrossRefPubMed
Okwundu C, Okoromah C: Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2009, 1.
•• Stirratt MJ, Gordon CM: Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep 2008, 5:186–192. This article provides insightful perspectives on the areas in which existing HIV adherence literature can inform research on biomedical prevention strategies. CrossRefPubMed
Sood N, Goldman D: HIV breakthroughs and risky sexual behavior. Q J Econ 2006, 121:1063–1102. CrossRef
Wetmore CM, Manhart LE, Wasserheit JN: Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future. Epidemiol Rev 2010, In press.
Rotheram-Borus M, Swendeman D, Chovnick G: The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Ann Rev Clin Psychol 2009, 5:143–167. CrossRef
•• Munro S, Lewin S, Swart T, Volmink J: A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 2007, 7:104. This paper provides one of the most comprehensive reviews and analysis of behavioral change theories and the evidence for their effectiveness in predicting and affecting behavior change. CrossRefPubMed
Golub SA, Kowalczyk WJ, Weinberger CL, Parsons JT: Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr 2010, In press.
• Reyna VF: A theory of medical decision making and health: Fuzzy trace theory. Med Decis Making 2008, 28:850–865. This article discusses the application of Fuzzy Trace Theory to health and medical decision-making. It provides a novel approach to understanding risk perception and behavior, and applies existing data to the development of theory-based intervention strategies. CrossRefPubMed
Reyna VF: How people make decisions that involve risk: A dual process approach. Curr Dir Psychol Sci 2004, 13:60–66. CrossRef
Zajonc RB: On the primacy of affect. Am Psychol 1984, 39:117–123. CrossRef
•• Gutnik LA, Hakimzada AF, Yoskowitz NA, Patel VL: The role of emotion in decision-making: a cognitive neuroeconomic approach towards understanding sexual risk behavior. J Biomed Inform 2006, 39:720–736. This article develops a new cognitive neuroscience model of risky decision-making, which incorporates a large body of scientific literature across disciplines. It is both complex and innovative, and has important implications for HIV research. CrossRefPubMed
Charng H, Piliavin JA, Callero PL: Role-identity and reasoned action in the prediction of repeated behavior. Soc Psychol Q 1988, 51:303–317. CrossRef
Hagger M, Anderson M, Kyriak M, Darkings S: Aspects of identity and their influence on intentional behavior: Comparing effects for three health behaviors. Pers Individ Dif 2007, 42:355–367. CrossRef
Pierro A, Mannetti L, Livi S: Self identity and the theory of planned behavior in the prediction of health behavior and leisure activity. Self Identity 2003, 2:47–60. CrossRef
- Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research and Implementation
Sarit A. Golub
Pamina M. Gorbach
- Current Science Inc.